Vancomycin is available under several brand names, most notably Vancocin [1]. Other brand names for vancomycin include Lyphocin and Vancor [2].
Why are there different names for Vancomycin?
The presence of multiple names reflects different manufacturers and formulations of the same active ingredient, vancomycin. Vancocin is a widely recognized brand, but other companies also produce generic or branded versions of the antibiotic [1, 2].
When does the patent for Vancocin expire?
Information on the specific patent expiration dates for Vancocin is not readily available in the provided context. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity periods, which could offer more detailed information [3].
Who makes generic vancomycin?
Several pharmaceutical companies manufacture generic versions of vancomycin. These generics are approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) after demonstrating bioequivalence to the branded product [4].
What is vancomycin used to treat?
Vancomycin is a powerful antibiotic used to treat serious infections caused by Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) [5]. It is often reserved for cases where other antibiotics are not effective or for patients who cannot tolerate them [6].
What are the common side effects of vancomycin?
Common side effects associated with vancomycin include kidney problems, infusion reactions (such as red man syndrome), and a decrease in the number of white blood cells [7]. Serious side effects can also occur, and patients should discuss any concerns with their healthcare provider [8].
How is vancomycin administered?
Vancomycin is typically administered intravenously (through an IV) [1]. In some cases, it may be given orally to treat certain intestinal infections, such as those caused by Clostridium difficile [9].
How does vancomycin work?
Vancomycin belongs to a class of drugs called glycopeptide antibiotics. It works by inhibiting bacterial cell wall synthesis, which leads to the death of susceptible bacteria [5].
What are the risks of vancomycin treatment?
Potential risks include ototoxicity (hearing damage) and nephrotoxicity (kidney damage) [7]. Close monitoring of kidney function and drug levels in the blood is essential during treatment to minimize these risks [8].
Are there alternatives to vancomycin?
For certain infections, alternative antibiotics may be considered, depending on the specific pathogen, its susceptibility, and the patient's medical history. However, for severe MRSA infections, vancomycin remains a cornerstone of treatment [6].
Sources
1. Drug Patent Watch
2. GoodRx
3. Drug Patent Watch
4. U.S. Food and Drug Administration (FDA)
5. National Institutes of Health (NIH) - MedlinePlus
6. Centers for Disease Control and Prevention (CDC)
7. Mayo Clinic
8. WebMD
9. Cleveland Clinic